Market Sentiment for LLY

Live Market Sentiment

Neutral (-0.0632)

(Latest daily score)

Predicted Return

25.69%

7-day sentiment average

Advisory Opinion

Buy

Derived from sentiment trend

News Items (period)

7,324

The table below gives each of the most recent headlines of the stock and the negative, neutral, positive aggregated sentiment score.

Date	Headline	Source	Sentiment
2026-04-04	Jim Cramer Believes Eli Lilly’s “Weight Loss Pill Will Be a Blockbuster”	Insider Monkey	Strong Positive (0.7598)
2026-04-04	Jim Cramer Likes Eli Lilly’s (LLY) New Deal	Insider Monkey	Neutral (0.0899)
2026-04-04	Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight	Motley Fool	Negative (-0.1280)
2026-04-04	The Next Big AI Winner Might Not Be a Tech Company	Barchart	Neutral (0.0462)
2026-04-04	Why Eli Lilly (LLY) Is Up 6.5% After FDA Approval of Foundayo Oral Obesity Pill	Simply Wall St.	Strong Positive (0.9338)
2026-04-03	Where the New Houses Are—and What That Says About Growth	Barrons.com	Neutral (0.0006)
2026-04-03	Why Novo Nordisk's Pricing Shift Could Unlock a Much Larger Obesity Market	Motley Fool	Neutral (0.0933)
2026-04-03	Health Care Roundup: Market Talk	The Wall Street Journal	Neutral (0.0251)
2026-04-03	Eli Lilly (LLY) Receives FDA Approval for Foundayo Weight Management Pill	Insider Monkey	Strong Positive (0.8696)
2026-04-03	Why investors are so eager for the SpaceX IPO countdown	MarketWatch	Neutral (0.0480)